| Symbol |
Name |
|
AMH
|
anti-Mullerian hormone
|
|
APOD
|
apolipoprotein D
|
|
AR
|
androgen receptor
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BMP15
|
bone morphogenetic protein 15
|
|
CAT
|
catalase
|
|
CBX2
|
chromobox homolog 2
|
|
CD38
|
CD38 molecule
|
|
CHMP1B
|
charged multivesicular body protein 1B
|
|
CLDN14
|
claudin 14
|
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DHH
|
desert hedgehog
|
|
DHX37
|
DEAH (Asp-Glu-Ala-His) box polypeptide 37
|
|
DMD
|
dystrophin
|
|
DMRT1
|
doublesex and mab-3 related transcription factor 1
|
|
DMRT2
|
doublesex and mab-3 related transcription factor 2
|
|
DMRT3
|
doublesex and mab-3 related transcription factor 3
|
|
ERAL1
|
Era-like 12S mitochondrial rRNA chaperone 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAM189A2
|
family with sequence similarity 189, member A2
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FLNB
|
filamin B, beta
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXL2
|
forkhead box L2
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GART
|
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
|
|
GATA4
|
GATA binding protein 4
|
|
GCG
|
glucagon
|
|
GDF9
|
growth differentiation factor 9
|
|
GH1
|
growth hormone 1
|
|
GTF2E2
|
general transcription factor IIE, polypeptide 2, beta 34kDa
|
|
GTF2H5
|
general transcription factor IIH, polypeptide 5
|
|
HARS1
|
histidyl-tRNA synthetase 1
|
|
HARS2
|
histidyl-tRNA synthetase 2, mitochondrial
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
LARS2
|
leucyl-tRNA synthetase 2, mitochondrial
|
|
LHX9
|
LIM homeobox 9
|
|
MAMLD1
|
mastermind-like domain containing 1
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MPLKIP
|
M-phase specific PLK1 interacting protein
|
|
MRPS22
|
mitochondrial ribosomal protein S22
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NUP107
|
nucleoporin 107kDa
|
|
PAICS
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PGD
|
phosphogluconate dehydrogenase
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
|
POLR3H
|
polymerase (RNA) III (DNA directed) polypeptide H (22.9kD)
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
|
PPP2R3C
|
protein phosphatase 2, regulatory subunit B'', gamma
|
|
PSMC3IP
|
PSMC3 interacting protein
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RNF113A
|
ring finger protein 113A
|
|
RPS2
|
ribosomal protein S2
|
|
RPS4X
|
ribosomal protein S4, X-linked
|
|
SF1
|
splicing factor 1
|
|
SGOL2
|
shugoshin-like 2 (S. pombe)
|
|
SGSM3
|
small G protein signaling modulator 3
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHOX
|
short stature homeobox
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SOX8
|
SRY (sex determining region Y)-box 8
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPIDR
|
scaffolding protein involved in DNA repair
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRY
|
sex determining region Y
|
|
SSRP1
|
structure specific recognition protein 1
|
|
STARD8
|
StAR-related lipid transfer (START) domain containing 8
|
|
STK11
|
serine/threonine kinase 11
|
|
TBC1D24
|
TBC1 domain family, member 24
|
|
TMEM5
|
transmembrane protein 5
|
|
TOE1
|
target of EGR1, member 1 (nuclear)
|
|
TPO
|
thyroid peroxidase
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TSPY10
|
testis specific protein, Y-linked 10
|
|
TSPY3
|
testis specific protein, Y-linked 3
|
|
TWNK
|
twinkle mtDNA helicase
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
ZFPM2
|
zinc finger protein, FOG family member 2
|
|
ZFY
|
zinc finger protein, Y-linked
|
